Royal Bank of Canada reissued their outperform rating on shares of Spire Healthcare Group (LON:SPI) in a research note issued to investors on Monday, Digital Look reports. The brokerage currently has a GBX 149 ($1.95) price target on the stock.

A number of other research analysts also recently weighed in on the company. Barclays reissued an underweight rating and issued a GBX 115 ($1.50) target price on shares of Spire Healthcare Group in a report on Friday, August 9th. UBS Group started coverage on Spire Healthcare Group in a report on Tuesday, July 2nd. They issued a neutral rating and a GBX 120 ($1.57) target price on the stock. Peel Hunt reissued a hold rating on shares of Spire Healthcare Group in a report on Monday, September 2nd. Liberum Capital reissued a hold rating on shares of Spire Healthcare Group in a report on Monday, August 5th. Finally, Numis Securities reissued a buy rating and issued a GBX 163 ($2.13) target price (down previously from GBX 280 ($3.66)) on shares of Spire Healthcare Group in a report on Thursday, May 16th. Two analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of GBX 126.56 ($1.65).

SPI stock opened at GBX 123.40 ($1.61) on Monday. Spire Healthcare Group has a fifty-two week low of GBX 95.25 ($1.24) and a fifty-two week high of GBX 176 ($2.30). The business’s 50-day moving average is GBX 105.60 and its two-hundred day moving average is GBX 121.44. The company has a debt-to-equity ratio of 48.52, a quick ratio of 0.95 and a current ratio of 1.44. The company has a market cap of $494.93 million and a price-to-earnings ratio of 44.07.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Article: How to Invest in Stocks with Increasing Dividends

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.